3 Biotech Stocks to Buy in April

Biotech stocks, in general, again performed dismally in the first quarter of 2022. However, there are some signs of improvement. The lower valuations could present a great buying opportunity once the inevitable strong rebound materializes.

We asked three Motley Fool contributors which biotech stocks they think are good picks to buy in April. Here's why they chose Amgen (NASDAQ: AMGN), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Novocure (NASDAQ: NVCR).

Image source: Getty Images.

Continue reading

Source Fool.com